Non-glutamate Type Pyrrolo[2,3-d]pyrimidine Antifolates. II. Synthesis and Antitumor Activity of N^5-Substituted Glutamine Analogs
スポンサーリンク
概要
- 論文の詳細を見る
The glutamic acid moiety of N-[4-[3-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)propyl]benzoyl]-L-glutamic acid (1b, TNP-351) and related compounds was replaced with some N^5-substituted glutamines. Antifolates (4A-S) were effectively prepared by coupling pyrrolo[2,3-d]pyrimidine carboxylic acids (11a, b) with some properly protected N^5-substituted glutamine derivatives (10A-S), which were prepared by coupling Boc-Glu-OMe (7) with various amines (8A-S) using a suitable condensing reagent, followed by hydrolysis. The inhibitory effects of the resulting products on dihydrofolate reductase (DHFR), thymidylate synthetase (TS) and the growth of murine fibrosarcoma Meth A cells in culture were examined. All N^5-substituted glutamine analogs (4A-S) inhibited DHFR much more strongly than TNP-351 and some analogs exhibited the same potent growth inhibition of Meth A cells as TNP-351. Some typical analogs (4Bb, 4Db, 4F, 4Oa) were also examined for inhibitory effects on the growth of methotrexate (MTX)-resistant human CCRF-CEM cells in culture and for in vivo antitumor activities against murine leukemia and solid tumors. MTX-resistant cells, with a defect in transport and decreased polyglutamylation activity, showed little cross resistance to the analog (4Oa) having a tetrazole moiety as a substituent of glutamine, which exhibited potent antitumor activities. These results demonstrate that the antifolate analogs (4) with N^5-substituted glutamine in place of glutamic acid are novel potent DHFR inhibitors with activity against MTX-resistant tumors. The potent antitumor activity of these analogs (4) may result from their effective uptake via reduced folate carrier in combination with their potent inhibition of DHFR.
- 公益社団法人日本薬学会の論文
- 1996-08-15
著者
-
Itoh F
Division Of Gastroenterology And Hepatology Department Of Internal Medicine St Marianna University S
-
Itoh Fumio
Division Of Gastroenterology And Hepatology Department Of Internal Medicine St Marianna University S
-
吉田 茂男
The Institute Of Physical And Chemical Research
-
YOSHIDA SEI
Pharmaceutical Research Division, Takeda Chemical Industries
-
Itoh Fumio
Pharmaceutical Research Laboratories Iii. Takeda Chemical Industries Ltd.
-
Itoh Fumio
Pharmaceutical Research Division Takeda Chemical Industries Ltd.
-
Yoshida S
Biological Research Laboratories Sankyo Co. Ltd.
-
Yoshida Sei
Pharmaceutical Research Division Takeda Chemical Industries
-
Akimoto H
Intellectual Property Department Takeda Chemical Industries Ltd.
-
YOSHIOKA Yoshio
Medicinal Chemistry Research Laboratories, Takeda Chemical Industries, Ltd.,
-
YUKISHIGE Koichi
Pharmaceutical Business Development Department Takeda Chemical Industries, Ltd.,
-
AKIMOTO Hiroshi
Intellectual Property Department, Takeda Chemical Industries, Ltd.,
-
YOSHIOKA Yoshio
Pharmaceutical Research Laboratories III, Takeda Chemical Industries, Ltd.
-
WAJIMA Megumi
Pharmaceutical Research Laboratories III, Takeda Chemical Industries, Ltd.
-
OOTSU Koichiro
Pharmaceutical Research Laboratories III, Takeda Chemical Industries, Ltd.
-
Wajima M
Pharmaceutical Research Laboratories Iii Takeda Chemical Industries Ltd.
-
Wajima Megumi
Pharmaceutical Research Laboratories Iii. Takeda Chemical Industries Ltd.
-
Ootsu K
Takeda Rabics Takeda Chemical Industries Ltd.
-
Ootsu Koichiro
Pharmaceutical Research Laboratories I Pharmaceutical Research Division Takeda Chemical Industries
-
Ypshioka Y
Medicinal Chemistry Research Laboratories Takeda Chemical Industries Ltd.
-
Wajima Megumi
Pharmaceutical Research Laboratories Iii Takeda Chemical Industries Ltd.
-
Yukishige K
Pharmaceutical Business Development Department Takeda Chemical Industries Ltd.
-
AKIMOTO Hiroshi
Intellectual Property Department, Takeda Chemical Industries, Ltd.
関連論文
- Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C
- スズメノカタビラの s-トリアジン除草剤抵抗性の分子機構および異なる光条件下における光合成機能
- Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B
- Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response
- Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis
- Effect of treatment with interferon α-2b and ribavirin in patients infected with genotype 2 hepatitis C virus
- A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C
- Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder
- Screening of Inhibitor of Eukaryotic DNA Polymerases Produced by Microorganisms
- Galactosyldiacylglycerol, a Mammalian DNA Polymerase α-Specific Inhibitor from a Sea Alga, Petalonia bingbamiae
- The Cyanogenic Glucoside, Prunasin (D-Mandelonitrile-β-D-Glucoside), Is a Novel Inhibitor of DNA Polymerase β
- Action of a New Mammalian DNA Polymerase Inhibitor, Sulfoquinovosyldiacylglycerol
- Sulfoquinovosyldiacylglycerol, KM043,a New Potent Inhibitor of Eukaryotic DNA Polymerases and HIV-Reverse Transcriptase Type 1 from a Marine Red Alga, Gigartina tenella
- Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives
- Divergent roles of tumor suppressor gene Klf6 in ES cell differentiation
- Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo
- Four Euglobals from Eucalyptus blakelyi
- Inhibitors of Skin-Tumor Promotion. VIII. : Inhibitory Effects of Euglobals and Their Related Compounds on Epstein-Barr Virus Activation. (1)
- Increased phosphorylation of Akt in triple-negative breast cancers
- Non-glutamate Type Pyrrolo[2,3-d]pyrimidine Antifolates. III. Synthesis and Biological Properties of N^ω-Masked Ornithine Analogs
- Non-glutamate Type Pyrrolo[2,3-d]pyrimidine Antifolates. II. Synthesis and Antitumor Activity of N^5-Substituted Glutamine Analogs
- Enzyme-inhibition system for identifying potential antimalarials that target highly drug-resistant mutants of Plasmodium falciparum dihydrofolate reductase
- Epigenetics modulates the effect of chemotherapy on gastric cancer
- Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease
- Non-glutamate Type Pyrrolo[2,3-d]pyrimidine Antifolates. I : Synthesis and Biological Properties of Pyrrolo[2,3-d]pyrimidine Antifolates Containing Tetrazole Congener of Glutamic Acid
- Synthesis and Structure-Activity Relationships of TAN-1511 Analogues as Potent Hematopoietic Agents
- Synthesis and Biological Activities of TAN-1511 Analogues
- Allixin Accumulation with Long-term Storage of Garlic
- Antitumor Effects of 5'-Deoxy-5-fluorouridine in Combination with Recombinant Human Interleukin 2 on Murine Colon Carcinoma 26
- Pyrrolo[2, 3-d]pyrimidine Thymidylate Synthase Inhibitors : Design and Synthesis of One-Carbon Bridge Derivatives
- Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography : can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?